What are the recommended doses of salbutamol (albuterol) and ipratropium bromide (PNSS) via nebule for a 3-month-old infant weighing 5.5 kilograms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Salbutamol Dosing for a 3-Month-Old Infant (5.5 kg)

For a 3-month-old infant weighing 5.5 kg with acute bronchospasm, administer 2.5 mg of nebulized salbutamol diluted in 2-3 mL of normal saline via face mask every 20 minutes for up to 3 doses, then continue with 2.5 mg every 1-4 hours as needed based on clinical response. 1, 2

Initial Treatment Protocol

  • Start with 2.5 mg salbutamol (the minimum effective dose) rather than weight-based dosing (which would calculate to 0.15 mg/kg × 5.5 kg = 0.825 mg), as the fixed 2.5 mg dose is as effective as weight-based dosing in infants and young children with mild to moderate acute asthma 1, 2

  • Dilute in 2-3 mL of normal saline for adequate nebulization 1

  • Use a face mask rather than a mouthpiece for delivery, as infants will not tolerate a mouthpiece 2, 3

  • Administer every 20 minutes for 3 doses in the first hour for acute exacerbations 4, 2

  • Continue with 2.5 mg every 1-4 hours as needed based on clinical response after the initial 3 doses 1, 2

Critical Administration Details

  • Use oxygen as the gas source for nebulization when available, with supplemental oxygen administered to maintain oxygen saturation >92% during treatment 1, 2

  • Monitor continuously: heart rate, respiratory rate, oxygen saturation, and clinical response after each nebulization 1, 3

  • Watch for side effects: tachycardia, tremors, and hypokalemia from overdosing 2, 3

Important Considerations for Infants

  • Salbutamol should be restricted to symptomatic infants with obvious bronchospasm and is not recommended for routine use in all infants due to variable response 3

  • Response is primarily dependent on symptom status and presence of lung function abnormalities in this age group 3

  • Begin simultaneous treatment with corticosteroids for acute asthma exacerbations (prednisolone 1-2 mg/kg/day, maximum 60 mg/day) 4, 2

Regarding Ipratropium Bromide (PNSS is Normal Saline, Not Ipratropium)

Note: PNSS refers to "physiologic normal saline solution" (0.9% NaCl), which is the diluent for nebulization, NOT ipratropium bromide.

If you are asking about ipratropium bromide dosing:

  • For infants and children <12 years: 0.25 mg (250 mcg) nebulized every 20 minutes for 3 doses, then as needed 4

  • Can be mixed with salbutamol in the same nebulizer 4

  • Should be added to salbutamol therapy for severe exacerbations only, not as first-line therapy 4

  • The addition of ipratropium has not been shown to provide further benefit once the patient is hospitalized 4

  • For moderate-to-severe asthma exacerbations, combination therapy may reduce hospital admission risk compared to salbutamol alone 5

Common Pitfalls to Avoid

  • Do not underdose: Using less than 2.5 mg may result in inadequate bronchodilation and treatment failure 2

  • Do not use a mouthpiece: Infants require face mask delivery for effective nebulization 2

  • Do not delay corticosteroids: Begin systemic corticosteroids early in acute exacerbations 2

  • Do not add ipratropium routinely: Reserve for severe exacerbations only, as it provides no additional benefit in mild-moderate cases or after hospitalization 4

References

Guideline

Salbutamol Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Salbutamol Nebulization Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Salbutamol Use in Symptomatic Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.